Sun.Jan 21, 2024

article thumbnail

Join DDW for the SLAS2024 Ignite Theater ‘Innovation from lab to patient’

Drug Discovery World

SLAS2024 International Conference and Exhibition takes place in Boston, USA, on 3-7 February. DDW will be hosting two conference tracks highlighting expertise in the lab to patient process. In a new feature for SLAS2024, DDW will be hosting a programme of presentations at the Ignite Theater located in the exhibition hall on 5 and 6 February: ‘Innovation & technology: from lab to patient’.

Vaccine 130
article thumbnail

Deliberate Dysentery

Codon

Introduction The intentional infection of human beings with pathogens under study has been going on for centuries. In 1796, an English physician named Edward Jenner inoculated an 8-year-old boy against smallpox with cowpox lesions he retrieved from the hands of a dairymaid. Today, refined versions of these human challenge studies have become standard practice in testing vaccines for vector-borne diseases (e.g., yellow fever, malaria, and dengue), evaluating new drugs or treatments, and studying

Vaccine 119
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The megalodon was less mega than previously believed

Science Daily: Pharmacology News

A new study shows the Megalodon, a gigantic shark that went extinct 3.6 million years ago, was more slender than earlier studies suggested. This finding changes scientists' understanding of Megalodon behavior, ancient ocean life, and why the sharks went extinct.

89
article thumbnail

New patent expiration for Mayne Pharma drug RHOFADE

Drug Patent Watch

Annual Drug Patent Expirations for RHOFADE Rhofade is a drug marketed by Mayne Pharma and is included in one NDA. It is available from one supplier. There are eight patents… The post New patent expiration for Mayne Pharma drug RHOFADE appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 59
article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

JavaScript: To understand the basic differences between arrays and sets.

Perficient: Drug Development

1. Introduction The two most common types of data structures to be used in programming are arrays and sets. They may seem to be the same, but in terms of their properties and abilities there are distinct differences. To optimize their code and make it work better, developers need to understand these differences. We’ll be comparing arrays and sets on the blog, detailing their specific features as well as case studies.

52
article thumbnail

Pharmaceutical companies with the most ‘New Patient Population’ drugs

Drug Patent Watch

This chart shows the companies which have received the most New Patient Population exclusivities in the past five years. New Patient Populations are one of the categories for which the… The post Pharmaceutical companies with the most ‘New Patient Population’ drugs appeared first on DrugPatentWatch - Make Better Decisions.

article thumbnail

Shameless Plug – Thursday’s CLE Webinar on the Best and Worst Drug/Medical Device Decisions of 2023

Drug & Device Law

For any of our loyal readers looking to start the New Year with a healthy helping of CLE credit, a friendly reminder that four of your bloggers – Bexis, Steven Boranian, Stephen McConnell, and Lisa Baird – will be presenting a free 90-minute CLE webinar on “The good, the bad and the ugly: The best and worst drug/medical device decisions of 2023” on Thursday, January 25th at 12 p.m.